Home
MREO
MREO News

Latest Mereo BioPharma Group plc (MREO) News on September 15, 2025

MT Newswires

5 days ago

European Equities Traded in the US as American Depositary Receipts Little Changed in Wednesday Trading

Ultragenyx, Mereo Hammered For Their Surprise Miss In Brittle Bone Disease

Investor's Business Daily

2 months ago

Ultragenyx, Mereo Hammered For Their Surprise Miss In Brittle Bone Disease

MT Newswires

2 months ago

Top Midday Decliners

MT Newswires

2 months ago

European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading

Biotech Stock Ultragenyx Is Falling on Unsatisfying Trial Update

Barrons.com

2 months ago

Biotech Stock Ultragenyx Is Falling on Unsatisfying Trial Update

MT Newswires

2 months ago

Ultragenyx Shares Drop as Osteogenesis Trial Update Disappoints Investors

MT Newswires

2 months ago

Sector Update: Health Care Stocks Mixed Premarket Thursday

MT Newswires

2 months ago

Sector Update: Health Care

MT Newswires

2 months ago

Ultragenyx, Mereo Advance Phase 3 Study of Genetic Bone Disorder Toward Final Analysis

MT Newswires

3 months ago

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Up 2.5% for Week

MT Newswires

3 months ago

European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading

MT Newswires

3 months ago

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

High Growth Tech Stocks To Watch In The US June 2025

Simply Wall St.

3 months ago

High Growth Tech Stocks To Watch In The US June 2025

Promising Penny Stocks To Consider In June 2025

Simply Wall St.

3 months ago

Promising Penny Stocks To Consider In June 2025

Mereo BioPharma Group plc (NASDAQ:MREO): Is Breakeven Near?

Simply Wall St.

3 months ago

Mereo BioPharma Group plc (NASDAQ:MREO): Is Breakeven Near?

We're Not Very Worried About Mereo BioPharma Group's (NASDAQ:MREO) Cash Burn Rate

Simply Wall St.

4 months ago

We're Not Very Worried About Mereo BioPharma Group's (NASDAQ:MREO) Cash Burn Rate

Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights

GlobeNewswire

4 months ago

Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights

Mereo BioPharma Group plc (MREO): A Bull Case Theory

Insider Monkey

5 months ago

Mereo BioPharma Group plc (MREO): A Bull Case Theory

Is Mereo BioPharma Group (NASDAQ:MREO) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Insider Monkey

5 months ago

Is Mereo BioPharma Group (NASDAQ:MREO) the Best Biotech Penny Stock to Buy According to Hedge Funds?

MT Newswires

6 months ago

JPMorgan Initiates Coverage on Mereo BioPharma Group With Overweight Rating, $7 Price Target

Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights

GlobeNewswire

6 months ago

Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights

MEREO BIOPHARMA (MREO) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

6 months ago

MEREO BIOPHARMA (MREO) Upgraded to Buy: What Does It Mean for the Stock?

Exploring High Growth Tech Stocks In The US Market

Simply Wall St.

6 months ago

Exploring High Growth Tech Stocks In The US Market

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference

GlobeNewswire

6 months ago

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference

Mereo Insurance forays into reinsurance market

Life Insurance International

7 months ago

Mereo Insurance forays into reinsurance market

Ex-AIG Chief Secures $700 Million for Mereo Reinsurance Startup

Bloomberg

7 months ago

Ex-AIG Chief Secures $700 Million for Mereo Reinsurance Startup

Mereo BioPharma Provides Update on Lead Clinical Programs

GlobeNewswire

8 months ago

Mereo BioPharma Provides Update on Lead Clinical Programs

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

8 months ago

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Why Mereo BioPharma (MREO) Is One of the Best Biotech Penny Stocks to Invest in Now?

Insider Monkey

9 months ago

Why Mereo BioPharma (MREO) Is One of the Best Biotech Penny Stocks to Invest in Now?

Mereo BioPharma initiated with a Buy at Jefferies

TipRanks

9 months ago

Mereo BioPharma initiated with a Buy at Jefferies

Mereo BioPharma Stock Climbs Following Jefferies' Buy Rating, Upside Potential of 89%

GuruFocus.com

9 months ago

Mereo BioPharma Stock Climbs Following Jefferies' Buy Rating, Upside Potential of 89%

MT Newswires

9 months ago

Mereo BioPharma Shares Rise After Jefferies Begins Coverage at Buy

MT Newswires

9 months ago

Jefferies Initiates Mereo BioPharma at Buy With $7 Price Target

Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

GlobeNewswire

10 months ago

Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

10 months ago

Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Is Mereo BioPharma Group (MREO) the Hottest Penny Stock to Invest in According to Hedge Funds?

Insider Monkey

a year ago

Is Mereo BioPharma Group (MREO) the Hottest Penny Stock to Invest in According to Hedge Funds?

Mereo BioPharma Group plc (MREO): A Bull Case Theory

Insider Monkey

a year ago

Mereo BioPharma Group plc (MREO): A Bull Case Theory

Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

GlobeNewswire

a year ago

Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 07/01/2024

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 06/28/2024

Investing.com

a year ago

Street calls of the week: Upgrade for Shopify; downgrades for AMD, Paramount

MT Newswires

a year ago

Mereo BioPharma Prices $50 Million Offering

Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market

GlobeNewswire

a year ago

Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market

MT Newswires

a year ago

Update: Ultragenyx, Mereo BioPharma Shares Rise as Bone Disorder Drug Shows Reduced Fracture Rate

Ultragenyx (RARE) Posts New Data From Bone Disease Study

Zacks

a year ago

Ultragenyx (RARE) Posts New Data From Bone Disease Study

MT Newswires

a year ago

Sector Update: Health Care Stocks Rise Premarket Wednesday

MT Newswires

a year ago

Sector Update: Health Care

$Ultragenyx, Mereo drug reduces fractures in bone disorder study$

BioPharma Dive

a year ago

Ultragenyx, Mereo drug reduces fractures in bone disorder study

MT Newswires

a year ago

Ultragenyx, Mereo BioPharma Say Phase 2 Study of Bone Disorder Drug Showed Reduced Fracture Rate

Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)

GlobeNewswire

a year ago

Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

a year ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

Business Wire

a year ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

AFP

a year ago

New Zealand scraps plan to tax livestock burps, farts

Business Wire

a year ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

The Wall Street Journal

a year ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool

Bloomberg

a year ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Simply Wall St.

a year ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

MEREO BIOPHARMA (MREO) Loses -12.74% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

a year ago

MEREO BIOPHARMA (MREO) Loses -12.74% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

a year ago

Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Mereo BioPharma Group PLC (MREO) Announces Full Year 2023 Financial Results

GuruFocus.com

a year ago

Mereo BioPharma Group PLC (MREO) Announces Full Year 2023 Financial Results

Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference

GlobeNewswire

2 years ago

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference

Ultragenyx (RARE) Q4 Loss Narrower Than Expected, Revenues Beat

Zacks

2 years ago

Ultragenyx (RARE) Q4 Loss Narrower Than Expected, Revenues Beat

15 Top Performing European Stocks So Far in 2024

Insider Monkey

2 years ago

15 Top Performing European Stocks So Far in 2024

Just Four Days Till Kearny Financial Corp. (NASDAQ:KRNY) Will Be Trading Ex-Dividend

Simply Wall St.

2 years ago

Just Four Days Till Kearny Financial Corp. (NASDAQ:KRNY) Will Be Trading Ex-Dividend

Is Atlanticus (ATLC) Stock Undervalued Right Now?

Zacks

2 years ago

Is Atlanticus (ATLC) Stock Undervalued Right Now?

Why the Market Dipped But Construction Partners (ROAD) Gained Today

Zacks

2 years ago

Why the Market Dipped But Construction Partners (ROAD) Gained Today

Associated Press Finance

2 years ago

Northfield: Q4 Earnings Snapshot

Northfield Bancorp, Inc. Announces the Appointment of Dr. Rachana A. Kulkarni to Its Board of Directors

GlobeNewswire

2 years ago

Northfield Bancorp, Inc. Announces the Appointment of Dr. Rachana A. Kulkarni to Its Board of Directors

Northfield Bancorp, Inc. Announces Fourth Quarter and Year End 2023 Results

GlobeNewswire

2 years ago

Northfield Bancorp, Inc. Announces Fourth Quarter and Year End 2023 Results

Hepsiburada Announces Changes to its Board of Directors

GlobeNewswire

2 years ago

Hepsiburada Announces Changes to its Board of Directors

Business Wire

2 years ago

nLIGHT to Announce Fourth Quarter 2023 Financial Results on February 22nd

Zacks Industry Outlook Highlights American Water Works, California Water Service, SJW Group and Consolidated Water

Zacks

2 years ago

Zacks Industry Outlook Highlights American Water Works, California Water Service, SJW Group and Consolidated Water

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2023 Financial Results

GlobeNewswire

2 years ago

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2023 Financial Results

Reasons to Add SJW Group (SJW) Stock to Your Portfolio Now

Zacks

2 years ago

Reasons to Add SJW Group (SJW) Stock to Your Portfolio Now

Estimating The Intrinsic Value Of GeoPark Limited (NYSE:GPRK)

Simply Wall St.

2 years ago

Estimating The Intrinsic Value Of GeoPark Limited (NYSE:GPRK)

Calculating The Fair Value Of nLIGHT, Inc. (NASDAQ:LASR)

Simply Wall St.

2 years ago

Calculating The Fair Value Of nLIGHT, Inc. (NASDAQ:LASR)

MainStay CBRE Global Infrastructure Megatrends Term Fund (NYSE: MEGI) Declares Monthly Distribution for January 2024 and Availability of 19(a) Notice

PR Newswire

2 years ago

MainStay CBRE Global Infrastructure Megatrends Term Fund (NYSE: MEGI) Declares Monthly Distribution for January 2024 and Availability of 19(a) Notice

Bel Fuse (BELFB) Outperforms Broader Market: What You Need to Know

Zacks

2 years ago

Bel Fuse (BELFB) Outperforms Broader Market: What You Need to Know

Wolfe Research Initiates Coverage On Four Hotel REITs: How Do They Compare?

Benzinga

2 years ago

Wolfe Research Initiates Coverage On Four Hotel REITs: How Do They Compare?

Therapy’s New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution

InvestorPlace

2 years ago

Therapy’s New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution

Ultragenyx's (RARE) Preliminary 2023 Revenues Disappoint

Zacks

2 years ago

Ultragenyx's (RARE) Preliminary 2023 Revenues Disappoint

Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference

GlobeNewswire

2 years ago

Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference

Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments

GlobeNewswire

2 years ago

Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments

Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

2 years ago

Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference

MAG Announces the Appointment of Tom Peregoodoff to the Board of Directors as Part of Planned Board Succession

GlobeNewswire

2 years ago

MAG Announces the Appointment of Tom Peregoodoff to the Board of Directors as Part of Planned Board Succession

Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme

Business Wire

2 years ago

Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme

Seabridge Gold Expands Iskut's Bronson Slope Deposit

Newsfile

2 years ago

Seabridge Gold Expands Iskut's Bronson Slope Deposit

Hedge Funds Say These Penny Stocks Are Poised to Explode

Insider Monkey

2 years ago

Hedge Funds Say These Penny Stocks Are Poised to Explode

Investors Still Aren't Entirely Convinced By Trupanion, Inc.'s (NASDAQ:TRUP) Revenues Despite 27% Price Jump

Simply Wall St.

2 years ago

Investors Still Aren't Entirely Convinced By Trupanion, Inc.'s (NASDAQ:TRUP) Revenues Despite 27% Price Jump

Redwood Trust Inc's Dividend Analysis

GuruFocus.com

2 years ago

Redwood Trust Inc's Dividend Analysis

New Strong Buy Stocks for December 15th

Zacks

2 years ago

New Strong Buy Stocks for December 15th

Nu Skin (NUS) Down More Than 20% in 3 Months: Here's Why

Zacks

2 years ago

Nu Skin (NUS) Down More Than 20% in 3 Months: Here's Why

Could The Market Be Wrong About A10 Networks, Inc. (NYSE:ATEN) Given Its Attractive Financial Prospects?

Simply Wall St.

2 years ago

Could The Market Be Wrong About A10 Networks, Inc. (NYSE:ATEN) Given Its Attractive Financial Prospects?

12 Best Junior Silver Mining Stocks To Buy Now

Insider Monkey

2 years ago

12 Best Junior Silver Mining Stocks To Buy Now

Insider Sell Alert: Senior Vice President Daniel Malan Sells Shares of Kelly Services Inc (KELYA)

GuruFocus.com

2 years ago

Insider Sell Alert: Senior Vice President Daniel Malan Sells Shares of Kelly Services Inc (KELYA)

Share on Social Networks: